Variant · Snv
MARK3 NM_001128918.3(MARK3):c.1327A>G (p.Ser443Gly)
CI-VAR-00339171Explore in graph →p.Ser443GlyNM_001128918.3:c.1327A>GClinVar 3056411 rs56305318
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3056411 | Benign | no assertion criteria provided | 0 | MARK3-related disorder; Hepatocellular carcinoma; Nonpapillary renal cell carcinoma; Cervical cancer; Uterine corpus endometrial carcinoma; Colon adenocarcinoma; Sarcoma; Thyroid cancer, nonmedullary, 1; Malignant tumor of esophagus | germline | 2 | Sep 30, 2019 | clinvar |